Violation Tracker Individual Record

Company: 
Serono, S.A.
Current Parent Company: 
Merck KGaA (EMD)
Penalty: 
$704,000,000
Year: 
2005
Date: 
October 17, 2005
Offense Group: 
healthcare-related offenses
Primary Offense: 
off-label or unapproved promotion of medical products
Secondary Offense: 
False Claims Act and related
Violation Description: 

Swiss corporation, Serono, S.A., together with its U.S. subsidiaries and related entities, agreed to pay $704 million to resolve criminal charges and civil allegations in connection with illegal schemes to promote, market and sell its drug Serostim used to treat AIDS wasting, a condition involving profound involuntary weight loss in AIDS patients.

Level of Government: 
federal
Action Type: 
agency action
Agency: 
Justice Department Civil Division
Civil or Criminal Case: 
civil and criminal
HQ Country of Parent: 
Germany
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.